Shanghai Pulmonary Hospital, Shanghai, China
Clinical trials sponsored by Shanghai Pulmonary Hospital, Shanghai, China, explained in plain language.
-
Ancient herbs meet modern medicine in fight against early menopause
Disease control Not yet recruitingThis study is testing whether adding a traditional Chinese herbal formula called Huanjingjian decoction to standard hormone replacement therapy (HRT) helps women with premature ovarian insufficiency (early menopause). Researchers will compare the herbal formula plus HRT against a…
Phase: NA • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Apr 01, 2026 21:41 UTC
-
Study tests if less invasive lung surgery works as well for certain cancers
Disease control Not yet recruitingThis study aims to find out if a surgery that removes a smaller piece of the lung (segmentectomy) is as good as the standard surgery that removes a larger lobe (lobectomy) for people with a specific type of early-stage lung cancer. Researchers will enroll 587 patients and randoml…
Phase: PHASE3 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Pre-Surgery combo aims to shrink lung tumors
Disease control Not yet recruitingThis study is testing a three-drug combination (JSKN016, toripalimab, and carboplatin) given to patients before they have surgery for stage II or III non-small cell lung cancer. The goal is to see if this treatment can shrink or eliminate the tumor in the lung and nearby lymph no…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug combo aims to shrink tumors before lung cancer surgery
Disease control Not yet recruitingThis study is testing whether adding a targeted drug called Bozitinib to standard chemotherapy helps shrink tumors before surgery for people with a specific genetic change (MET-altered) in their stage IIA-IIIC non-small cell lung cancer. The main goal is to see if this combinatio…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New approach aims to make tough lung cancer treatment more tolerable
Disease control Not yet recruitingThis study is testing whether a comprehensive prevention plan can help Chinese patients with advanced lung cancer better tolerate treatment with the drug amivantamab. The plan aims to reduce common side effects like skin rash, infusion reactions, and blood clots. Researchers will…
Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Breakthrough hope for Drug-Resistant TB: shorter treatment with new pill
Disease control Not yet recruitingThis study is testing whether adding a new drug called acetohydroxamic acid (AHA) to existing shorter treatment regimens can help people with multidrug-resistant tuberculosis. Researchers will enroll 120 participants to see if the combination is safe and effective at clearing the…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Targeted drug trial aims to extend remission for Tough-to-Treat lung cancer
Disease control Not yet recruitingThis study is testing whether adding the targeted drug ensartinib after standard chemoradiation can better control advanced, inoperable lung cancer in patients with a specific genetic change (ALK mutation). It will involve about 45 patients who have completed initial treatment wi…
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
New Two-Pronged test aims to catch lung cancer sooner
Diagnosis Not yet recruitingThis study aims to develop a better method for finding lung cancer early by combining two tests: a low-dose CT scan and a new blood test that looks for cancer signals. It will enroll 14,300 people, including those with and without cancer, to see if using both tests together is mo…
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
New injection could ease agony after keyhole chest surgery
Symptom relief Not yet recruitingThis study is testing if a local anesthetic (bupivacaine) injected into the chest cavity can better control pain after minimally invasive chest surgery. Researchers will compare two different strengths of the drug against a placebo (saltwater) in 249 patients. The main goal is to…
Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC